Hi, what are you looking for?
BrainStorm Cell Therapeutics, an Israeli developer of adult stem cell technologies for neurodegenerative diseases, announced that the US Food and Drug Administration has designated...
– The company recently reported positive results in its first pre-clinical trial for the treatment of ALS. – Israeli biotechnology company Kadimastem announces today...
A new way to fight infection. The US Biomedical R&D Authority has awarded Israel’s Atox Bio $24 million to develop its treatments for severe infections. Atox...
– 2014 is shaping up to be a record year for the raising of capital says Hapoalim high tech head Yossi Vinitski. /By...
Israel’s LapSpace Medical, a portfolio company of The Trendlines Group, announced it completed a series of successful procedures, utilizing its inflatable laparoscopic retractor,...
Israel’s Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer and inflammatory diseases, has received a...
Janet Guyon, editor-in-chief of TheStreet.com, demanded a retraction of a Washington Post article by Steven Pearlstein alleging that TheStreet.com writer Adam Feuerstein was writing...
Atox Bio, an Israeli a clinical stage biotechnology company, has been awarded a $24 million contract to fight flesh eating diseases. No, such diseases...
Israel’s Algatechnologies has signed an R&D agreement with Germany’s SCHOTT AG, an international technology group. The firms stated that the purpose of the new...
Israel’s Kadimastem has been having much success with its revolutionary technology that uses microscopic stem cells to protect or repair brain function. Pharmaceutical giant Merck...